Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Amerge (Naratriptan hydrochloride) Tablets, 1 and 2.5 mg Glaxo Wellcome NDA 20-763 Amerge (Naratriptan) Tablets, GlaxoSmithKline NARATRIPTAN HYDROCHLORIDE Tablet; 1MG BASE AMERGE GLAXOSMITHKLINE 020763 NARATRIPTAN HYDROCHLORIDE Tablet; 2.5MG BASE AMERGE GLAXOSMITHKLINE | Naratriptan Tablets, Roxane Laboratories, Inc., Tentative Approval | Naratriptan Tablets, Sandoz Inc., Tentative Approval | Naratriptan (naratriptan hydrochloride)Tablets, Roxane Laboratories, Inc., Approval | Naratriptan (naratriptan hydrochloride) Tablets, Sandoz Inc., Approval | Naratriptan (naratriptan hydrochloride) Tablets, TEVA Pharmaceuticals, Approval | Amerge (naratriptan hydrochloride) Tablets, GlazoSmithKline, Approval | Naratriptan Tablets, Sun Pharmaceutical Industries, Ltd., Approval | Naratriptan Tablets, Indicus Pharma LLC, Approval | Naratriptan Tablets, Apotex Corp., Approval ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com